Latest Market Expansion News

4DMedical has secured $22.6 million through the exercise of deep in-the-money options, significantly strengthening its cash position to support the commercial rollout of its CT – VQ™ respiratory imaging technology.

Advance Metals has raised $13 million in a strongly supported placement led by global institutional investors, positioning the company to accelerate exploration across its high-grade silver and gold projects in Mexico and Victoria.

Micro-X has landed a $3.3 million order from the Malaysian Ministry of Health for its Rover Plus mobile X-ray units, marking a significant step in its Southeast Asian expansion. Delivery is set to begin in October 2025.

Altech has detailed its Sodium Nickel Chloride (SNC) battery technology designed specifically for hazardous explosive environments, highlighting superior safety, longevity, and minimal maintenance compared to traditional battery chemistries.

Orthocell has reported a record $3 million revenue for the September quarter, driven by strong sales of its nerve repair product Remplir™ in Australia and Singapore, with early US sales and Canadian market entry poised to accelerate growth.

Victory Metals has taken a significant step forward by signing a non-binding Letter of Intent with Sumitomo Corporation to supply heavy rare earths from its North Stanmore project, marking a deepening of their strategic partnership.

Biome Australia Limited has reported a record-breaking $5.94 million in sales revenue for Q1 FY26, surpassing forecasts and accelerating toward its ambitious Vision 27 revenue goals.

First Graphene’s PureGRAPH technology underpins a new solar thermal product range launched in the UK by Senergy Innovations, targeting significant energy savings and market growth ahead of the 2027 Future Homes Standard.

Nova Eye Medical has gained regulatory approval for its iTrack Advance glaucoma device in China, setting the stage for significant market expansion and sales growth from late fiscal 2026.

Aquirian Limited reports a 16.7% revenue increase alongside key operational advances at its Wubin facility and new leadership appointments, signaling strong momentum in mining services and technology.

ReNerve Ltd is rapidly advancing its nerve repair product portfolio, with four ranges expected on the market by the end of 2025 and expanding global distribution. Clinical studies highlight significant patient benefits, supporting the company’s growth in a booming biomaterials market.

Vection Technologies reports a 60% revenue surge in 1H25, secures a $21 million equity raise, and strengthens its position in defence AI and spatial computing with a robust $75 million sales pipeline.